Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0KV1Q
|
||||
| Former ID |
DCL001020
|
||||
| Drug Name |
Trafermin
|
||||
| Synonyms |
Fiblast; Fiblast (TN); Trafermin (genetical recombination); Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
|
||||
| Indication | Periodontitis [ICD9: 523.5; ICD10:K05.4] | Phase 3 | [536297] | ||
| Company |
Johnson & Johnson Licensee; Kaken Pharmaceutical
|
||||
| CAS Number |
CAS 131094-16-1
|
||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Fibroblast growth factor receptor 2 | Target Info | Activator | [536297] | |
| NetPath Pathway | IL1 Signaling Pathway | ||||
| PANTHER Pathway | FGF signaling pathway | ||||
| Pathway Interaction Database | FGF signaling pathway | ||||
| Reactome | Activated point mutants of FGFR2 | ||||
| WikiPathways | Regulation of Actin Cytoskeleton | ||||
| Ectoderm Differentiation | |||||
| Hair Follicle Development: Organogenesis (Part 2 of 3) | |||||
| Hair Follicle Development: Induction (Part 1 of 3) | |||||
| Cardiac Hypertrophic Response | |||||
| Signaling Pathways in Glioblastoma | |||||
| Neural Crest Differentiation | |||||
| Signaling by FGFR | |||||
| MicroRNAs in cardiomyocyte hypertrophy | |||||
| Angiogenesis | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.